Edition:
United Kingdom

Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

160.00INR
14 Jun 2019
Change (% chg)

Rs3.05 (+1.94%)
Prev Close
Rs156.95
Open
Rs156.90
Day's High
Rs161.50
Day's Low
Rs155.50
Volume
35,850
Avg. Vol
88,281
52-wk High
Rs287.20
52-wk Low
Rs137.75

Latest Key Developments (Source: Significant Developments)

Panacea Biotec Gets Azacitidine USFDA Approval For U.S. Market
Monday, 20 May 2019 

May 20 (Reuters) - Panacea Biotec Ltd ::PANACEA BIOTEC RECEIVES AZACITIDINE USFDA APPROVAL FOR US MARKET.  Full Article

Panacea Biotec Says India Resurgence Fund To Invest Up To $144 Mln In Co
Monday, 8 Apr 2019 

April 8 (Reuters) - PANACEA BIOTEC LTD : :INDIA RESURGENCE FUND ANNOUNCED INVESTMENT OF UP TO $144 MILLION IN CO.IINVESTMENT PROCEEDS WILL BE USED FOR, AMONG OTHERS, ONE-TIME SETTLEMENT WITH EXISTING LENDERS.INVESTMENT IS STRUCTURED VIA NCDS OF UP TO 8.64 BILLION RUPEES, SUBSCRIPTION AMOUNT OF 320 MILLION RUPEES FOR SHARE WARRANTS.SUBJECT TO EXERCISE OF WARRANTS, INDIARF, AFFILIATES, TO COLLECTIVELY OWN 10.4% STAKE CO.  Full Article

India's Panacea Biotec Posts Dec-Qtr Loss
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Panacea Biotec Ltd ::DEC QUARTER NET LOSS 230.2 MILLION RUPEES VERSUS LOSS OF 97.1 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 1.14 BILLION RUPEES VERSUS 1.52 BILLION RUPEES YEAR AGO.  Full Article

Panacea Biotec Gets Shareholders' Nod For Reappointment Of Rajesh Jain As MD
Monday, 1 Oct 2018 

Oct 1 (Reuters) - Panacea Biotec Ltd ::GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF SOSHIL KUMAR JAIN AS WHOLE-TIME DIRECTOR DESGINATED AS CHAIRMAN.GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF RAJESH JAIN AS MD.GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF SANDEEP JAIN AS JOINT MD.  Full Article

Panacea Biotec Enters Into Agreement With Natco Pharma And Breckenridge Pharma
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Panacea Biotec Ltd ::SAYS ENTERED INTO TRIPARTITE AGREEMENT WITH NATCO PHARMA AND BRECKENRIDGE PHARMACEUTICAL.AGREEMENT FOR THE MANUFACTURE AND SUPPLY OF AZACITIDINE INJECTION FOR THE U.S. MARKET.  Full Article

India's Panacea Biotec June-Qtr Net Loss Narrows
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Panacea Biotec Ltd ::JUNE QUARTER NET LOSS 368.3 MILLION RUPEES VERSUS LOSS OF 479.9 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 951.1 MILLION RUPEES VERSUS 1.08 BILLION RUPEES YEAR AGO.  Full Article

Panacea Biotec Approves Elevation Of Rajesh Jain To Position Of MD
Monday, 12 Mar 2018 

March 12 (Reuters) - Panacea Biotec Ltd ::SAYS CO APPROVED ELEVATION OF RAJESH JAIN, JOINT MD TO POSITION OF MD OF CO.  Full Article

Panacea Biotec Says U.S. FDA Accepts Co's Marketing Application For Generic Cancer Drug
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Panacea Biotec Ltd ::SAYS U.S. FDA ACCEPTS CO'S ANDA FOR PACLITAXEL PROTEIN BOUND PARTICLES.  Full Article

India's Panacea Biotec Sept-qtr loss widens
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Panacea Biotec Ltd :Sept quarter net loss 56.3 million rupees versus loss 49.5 million rupees year ago.Sept quarter total income from operations 1.54 billion rupees versus 1.62 billion rupees year ago.  Full Article

India's Panacea Biotec Sept-qtr loss widens
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Panacea Biotec Ltd :Sept quarter net loss 56.3 million rupees versus loss 49.5 million rupees year ago.Sept quarter revenue from operations 1.53 billion rupees versus 1.41 billion rupees year ago.  Full Article

No consensus analysis data available.